Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

Miscellaneous

Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell cancer or advanced or metastatic cutaneous squamous cell carcinoma.
Miscellaneous
II
Gibson, Mike
NCT04305795
VICCHN2055

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.
Breast
II
Mayer, Ingrid
NCT01042379
VICCBRE1951

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: